We are pleased to announce that @evaluatepharma
have acquired J+D Forecasting!
Exciting times are ahead.
Read more in their press release: https://t.co/VfwIaq9Euu
When it comes to launching a new drug, understanding the probability of success is key. We think AI can help us better assess the factors that influence success. https://t.co/13BAQMGNg6
#pharma#digitaltransformation#drugdiscovery#AI#ML#bigdata
Just 1 week until the Pharmaceutical Management Science Association (#PMSA) Global Summit!
We will be joining industry leaders on stage to present on #AI and ML in Pharma Forecasting as part of the exciting agenda.
Check out the full agenda here: https://t.co/vPhWQa2Vdm
A J+D client success story!
How we delivered a long-term forecast model 80% faster than before and with a significantly reduced cost as a result. A Win/Win for everyone!
Check out the details of this top pharma client success story: https://t.co/CEn0vIkAE2
The challenges of #patient flow analysis:
⇨ Accurate data
⇨ Ideal methodology
⇨ Complexity of models
Here are our key considerations for creating more accurate patient-based product forecasts.
https://t.co/5gGcr6Is0P
Loss of exclusivity (LoE) can have a significant impact on the original company’s bottom line.
So how do forecasting teams model loss of exclusivity and generics entering the market?
https://t.co/9CaA8Irbyz
#pharma#generics#drugdiscovery#JDForecasting
For people living with rare diseases, one of the major challenges is being able to receive a rapid and accurate diagnosis - taking five years on average!
A new wave of research utilising AI could change this.
Read on: https://t.co/3yd96fxvHp
#raredisease#AI#ML
Many pharma executives state lack of in-house knowledge and skills as the main barrier to adopting AI.
Vendor collaboration is the route to leveraging AI technology in their R&D processes.
https://t.co/FULbFvTYGh
#pharma#digitaltransformation#pharmtech#AI#JDForecasting
At J+D, we are passionate about making the forecasting process better and easier for everyone involved.
That's why we have developed FC365, a fully integrated platform which allows the forecasters to keep the models in Excel.
Watch to discover more: https://t.co/OhivuM9OKv
@pharmaphorum Thanks for the article inclusion. We are seeing a real disparity across pharma affiliates in relation to their digitalisation journey. Hope this insight shows the benefits of a unified approach.
Our Epi+ software helps you:
✅Produce unlimited epidemiology-based forecasts in-line with best practice.
✅Create consistent models quickly, for efficient decision making.
✅Develop existing models or create new ones.
Book a free demo with us: https://t.co/yTBnOOot5v
Writing in @pharmaphorum Kris Barker outlines how the right sales #forecasting approaches can help identify market opportunities and risks for #pharma.
https://t.co/PQpXLaMe17
By including the wider competitive set in the #forecasting process, #pharmaceutical companies can observe and visualise trends and patterns more clearly. This approach can provide valuable #insights.
https://t.co/EkUwn45qZg
Learn about the role epidemiology models play in strategic planning and decision-making in our latest short blog.
https://t.co/TzWDqKdID0
#EpidemiologicalForecasting#DataAnalysis
With our focus on shaping the future of pharmaceutical forecasting, J+D are already exploring the benefits of incorporating AI technology into our solutions.
Get in touch to book onto one of our expert seminars: [email protected]
By incorporating AI into forecasting, pharma can supercharge their data analysis and gain more flexibility and predictability in evaluating future opportunities for more informed decision making.
https://t.co/lolQaeCyjv
#AI#forecasting#pharmaceuticals
#forecast model build which took weeks is now achievable in days, delivering your forecasting solution sooner.
Find out why we are the obvious choice for custom model build: https://t.co/bx68YCxQGZ